Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift.

Møller P, Dominguez-Valentin M, Rødland EA, Hovig E.

Cancers (Basel). 2019 Jan 23;11(2). pii: E132. doi: 10.3390/cancers11020132.

2.

Molecular signatures reflecting microenvironmental metabolism and chemotherapy-induced immunogenic cell death in colorectal liver metastases.

Østrup O, Dagenborg VJ, Rødland EA, Skarpeteig V, Silwal-Pandit L, Grzyb K, Berstad AE, Fretland ÅA, Mælandsmo GM, Børresen-Dale AL, Ree AH, Edwin B, Nygaard V, Flatmark K.

Oncotarget. 2017 Jul 18;8(44):76290-76304. doi: 10.18632/oncotarget.19350. eCollection 2017 Sep 29.

3.

Colorectal cancer incidence in path_MLH1 carriers subjected to different follow-up protocols: a Prospective Lynch Syndrome Database report.

Seppälä T, Pylvänäinen K, Evans DG, Järvinen H, Renkonen-Sinisalo L, Bernstein I, Holinski-Feder E, Sala P, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Jenkins M, Genuardi M, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Frayling IM, Plazzer JP, Sampson JR, Capella G, Möslein G, Mecklin JP, Møller P; Mallorca Group.

Hered Cancer Clin Pract. 2017 Oct 10;15:18. doi: 10.1186/s13053-017-0078-5. eCollection 2017.

4.

Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate.

Ree AH, Russnes HG, Heinrich D, Dueland S, Boye K, Nygaard V, Silwal-Pandit L, Østrup O, Hovig E, Nygaard V, Rødland EA, Nakken S, Øien JT, Johansen C, Bergheim IR, Skarpeteig V, Sathermugathevan M, Sauer T, Lund-Iversen M, Beiske K, Nasser S, Julsrud L, Reisse CH, Ruud EA, Flørenes VA, Hagene KT, Aas E, Lurås H, Johnsen-Soriano S, Geitvik GA, Lingjærde OC, Børresen-Dale AL, Mælandsmo GM, Flatmark K.

ESMO Open. 2017 May 2;2(2):e000158. doi: 10.1136/esmoopen-2017-000158. eCollection 2017.

5.

Cancer risk and survival in path_MMR carriers by gene and gender up to 75 years of age: a report from the Prospective Lynch Syndrome Database.

Møller P, Seppälä TT, Bernstein I, Holinski-Feder E, Sala P, Gareth Evans D, Lindblom A, Macrae F, Blanco I, Sijmons RH, Jeffries J, Vasen HFA, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen JT, Jenkins MA, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Renkonen-Sinisalo L, Valentin MD, Frayling IM, Plazzer JP, Pylvanainen K, Genuardi M, Mecklin JP, Moeslein G, Sampson JR, Capella G; Mallorca Group.

Gut. 2018 Jul;67(7):1306-1316. doi: 10.1136/gutjnl-2017-314057. Epub 2017 Jul 28.

6.

Reply to Towfic and others' letter to the editor.

Nygaard V, Rødland EA, Hovig E.

Biostatistics. 2017 Jul 1;18(3):586-587. doi: 10.1093/biostatistics/kxx001. No abstract available.

PMID:
28334081
7.

Incidence of and survival after subsequent cancers in carriers of pathogenic MMR variants with previous cancer: a report from the prospective Lynch syndrome database.

Møller P, Seppälä T, Bernstein I, Holinski-Feder E, Sala P, Evans DG, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Jenkins M, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Renkonen-Sinisalo L, Frayling IM, Plazzer JP, Pylvanainen K, Genuardi M, Mecklin JP, Möslein G, Sampson JR, Capella G; Mallorca Group (http://mallorca-group.org).

Gut. 2017 Sep;66(9):1657-1664. doi: 10.1136/gutjnl-2016-311403. Epub 2016 Jun 3.

8.

Cancer incidence and survival in Lynch syndrome patients receiving colonoscopic and gynaecological surveillance: first report from the prospective Lynch syndrome database.

Møller P, Seppälä T, Bernstein I, Holinski-Feder E, Sala P, Evans DG, Lindblom A, Macrae F, Blanco I, Sijmons R, Jeffries J, Vasen H, Burn J, Nakken S, Hovig E, Rødland EA, Tharmaratnam K, de Vos Tot Nederveen Cappel WH, Hill J, Wijnen J, Green K, Lalloo F, Sunde L, Mints M, Bertario L, Pineda M, Navarro M, Morak M, Renkonen-Sinisalo L, Frayling IM, Plazzer JP, Pylvanainen K, Sampson JR, Capella G, Mecklin JP, Möslein G; Mallorca Group (http://mallorca-group.eu).

Gut. 2017 Mar;66(3):464-472. doi: 10.1136/gutjnl-2015-309675. Epub 2015 Dec 9.

9.

Methods that remove batch effects while retaining group differences may lead to exaggerated confidence in downstream analyses.

Nygaard V, Rødland EA, Hovig E.

Biostatistics. 2016 Jan;17(1):29-39. doi: 10.1093/biostatistics/kxv027. Epub 2015 Aug 13.

10.

Molecular subtyping for clinically defined breast cancer subgroups.

Zhao X, Rødland EA, Tibshirani R, Plevritis S.

Breast Cancer Res. 2015 Feb 26;17:29. doi: 10.1186/s13058-015-0520-4.

11.

A statistical model of ChIA-PET data for accurate detection of chromatin 3D interactions.

Paulsen J, Rødland EA, Holden L, Holden M, Hovig E.

Nucleic Acids Res. 2014 Oct;42(18):e143. doi: 10.1093/nar/gku738. Epub 2014 Aug 11.

12.

Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status.

Zhao X, Rødland EA, Sørlie T, Vollan HK, Russnes HG, Kristensen VN, Lingjærde OC, Børresen-Dale AL.

BMC Cancer. 2014 Mar 19;14:211. doi: 10.1186/1471-2407-14-211.

13.

Interplay of choline metabolites and genes in patient-derived breast cancer xenografts.

Grinde MT, Skrbo N, Moestue SA, Rødland EA, Borgan E, Kristian A, Sitter B, Bathen TF, Børresen-Dale AL, Mælandsmo GM, Engebraaten O, Sørlie T, Marangoni E, Gribbestad IS.

Breast Cancer Res. 2014 Jan 21;16(1):R5. doi: 10.1186/bcr3597.

14.

Compact representation of k-mer de Bruijn graphs for genome read assembly.

Rødland EA.

BMC Bioinformatics. 2013 Oct 23;14:313. doi: 10.1186/1471-2105-14-313.

15.

Predicting physical interactions between protein complexes.

Clancy T, Rødland EA, Nygard S, Hovig E.

Mol Cell Proteomics. 2013 Jun;12(6):1723-34. doi: 10.1074/mcp.O112.019828. Epub 2013 Feb 25.

16.

Combining gene signatures improves prediction of breast cancer survival.

Zhao X, Rødland EA, Sørlie T, Naume B, Langerød A, Frigessi A, Kristensen VN, Børresen-Dale AL, Lingjærde OC.

PLoS One. 2011 Mar 10;6(3):e17845. doi: 10.1371/journal.pone.0017845.

17.

Impact of DNA physical properties on local sequence bias of human mutation.

Nakken S, Rødland EA, Hovig E.

Hum Mutat. 2010 Dec;31(12):1316-25. doi: 10.1002/humu.21371. Epub 2010 Nov 16.

PMID:
20886615
18.

Unstable DNA repair genes shaped by their own sequence modifying phenotypes.

Falster DS, Nakken S, Bergem-Ohr M, Rødland EA, Breivik J.

J Mol Evol. 2010 Mar;70(3):266-74. doi: 10.1007/s00239-010-9328-0. Epub 2010 Mar 6.

19.

Characterization of the major formamidopyrimidine-DNA glycosylase homolog in Mycobacterium tuberculosis and its linkage to variable tandem repeats.

Olsen I, Balasingham SV, Davidsen T, Debebe E, Rødland EA, van Soolingen D, Kremer K, Alseth I, Tønjum T.

FEMS Immunol Med Microbiol. 2009 Jul;56(2):151-61. doi: 10.1111/j.1574-695X.2009.00562.x. Epub 2009 Jun 3.

20.

Predicting helix-helix interactions from residue contacts in membrane proteins.

Lo A, Chiu YY, Rødland EA, Lyu PC, Sung TY, Hsu WL.

Bioinformatics. 2009 Apr 15;25(8):996-1003. doi: 10.1093/bioinformatics/btp114. Epub 2009 Feb 25.

21.

Large-scale inference of the point mutational spectrum in human segmental duplications.

Nakken S, Rødland EA, Rognes T, Hovig E.

BMC Genomics. 2009 Jan 22;10:43. doi: 10.1186/1471-2164-10-43.

22.

Genetic interactions of DNA repair pathways in the pathogen Neisseria meningitidis.

Davidsen T, Tuven HK, Bjørås M, Rødland EA, Tønjum T.

J Bacteriol. 2007 Aug;189(15):5728-37. Epub 2007 May 18.

23.

RNAmmer: consistent and rapid annotation of ribosomal RNA genes.

Lagesen K, Hallin P, Rødland EA, Staerfeldt HH, Rognes T, Ussery DW.

Nucleic Acids Res. 2007;35(9):3100-8. Epub 2007 Apr 22.

24.

DNA repair profiles of disease-associated isolates of Neisseria meningitidis.

Davidsen T, Amundsen EK, Rødland EA, Tønjum T.

FEMS Immunol Med Microbiol. 2007 Mar;49(2):243-51. Epub 2007 Jan 26.

25.

Pseudoknots in RNA secondary structures: representation, enumeration, and prevalence.

Rødland EA.

J Comput Biol. 2006 Jul-Aug;13(6):1197-213.

PMID:
16901237
26.

Biased distribution of DNA uptake sequences towards genome maintenance genes.

Davidsen T, Rødland EA, Lagesen K, Seeberg E, Rognes T, Tønjum T.

Nucleic Acids Res. 2004 Feb 11;32(3):1050-8. Print 2004.

27.

An experimental study on effects of occlusion of the cystic duct in mice with or without emptying of the gallbladder.

Trondsen E, Rosseland AR, Clausen OP, Bakka A, Engh E, Rødland EA, Aasen AO.

Eur Surg Res. 1997;29(2):150-8.

PMID:
9058083
28.

A method for determining the size of internal pilot studies.

Sandvik L, Erikssen J, Mowinckel P, Rødland EA.

Stat Med. 1996 Jul 30;15(14):1587-90.

PMID:
8855484
29.

[Problems when swallowing tablets. A questionnaire study from general practice].

Andersen O, Zweidorff OK, Hjelde T, Rødland EA.

Tidsskr Nor Laegeforen. 1995 Mar 20;115(8):947-9. Norwegian.

PMID:
7709385

Supplemental Content

Loading ...
Support Center